The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.N. Bogolepova

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Cerebrolysin in the treatment of cognitive impairment

Authors:

A.N. Bogolepova

More about the authors

Views: 2600

Downloaded: 101


To cite this article:

Bogolepova AN. Cerebrolysin in the treatment of cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;123(3):20‑25. (In Russ.)
https://doi.org/10.17116/jnevro202312303120

Recommended articles:
Predictors of the effi­cacy of non-drug treatments for non-dementia vascular cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(5):83-88
Modern possibilities of early diagnosis of Alzheimer’s disease in patients with primary open-angle glaucoma. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(6):121-128
Cognitive impairment in patients with atrial fibrillation. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(8):12-20
Obstructive sleep apnea — unde­restimated cognitive impairments risk factor. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(8):36-41
Modern achievements in the diagnosis and treatment of glaucoma. Vestnik Ofta­lmologii. 2023;(3):96-106

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.